Top

Published in:

Open Access 01-12-2024 | Cervical Cancer | Research

Survivorship care plans and adherence to breast and cervical cancer screening guidelines among cancer survivors in a national sample

Authors: Marco Santos-Teles, Ganesh Modugu, Isabel C. Silva, Elisa V. Bandera, Mridula George, Bo Qin, Jonathan Smith, Ruth Stephenson, Malcolm D. Mattes, Mariam F. Eskander

Published in: Supportive Care in Cancer | Issue 12/2024

Abstract

Purpose

The impact of the components of survivorship care plans on adherence to cancer screening guidelines among cancer survivors is limited. We examined the association of receipt of treatment summaries, follow-up instructions, and type of doctor providing survivorship care with adherence to breast cancer screening (BCS) and cervical cancer screening (CCS) guidelines in female cancer survivors.

Methods

A cross-sectional analysis using Behavioral Risk Factor Surveillance System (BRFSS) data from 2014, 2016 and 2018 was conducted. BCS and CCS-eligible women were aged 40–74 and 30–64, respectively. BCS adherence was defined as a mammogram within 2 years and CCS adherence as a pap smear within 3 years or HPV test within 5 years. Univariate analysis with chi-square and multivariable logistic regression are reported.

Results

5,001 BCS and 3,014 CCS-eligible survivors were identified. In the BCS group, recipients of treatment summaries and follow-up instructions were significantly more adherent with BCS (84.1% vs. 77.4%; 83.4% vs. 74%, respectively, p < 0.001). In the CCS group, recipients of follow-up instructions were significantly more adherent with CCS (78.1% vs. 67.7%, p < 0.001). In both groups, there was no significant difference in BCS or CCS based on type of physician providing care (p = 0.087). On multivariate analysis, receipt of follow-up instructions was the only factor significantly associated with BCS (OR:2.81; 95%CI:1.76–4.49) and CCS (OR:3.14; 95%CI:1.88–5.23).

Conclusions

Follow-up instructions, as part of survivorship care plans, have the strongest association with BCS and CCS among female cancer survivors. Additional research should focus on improving the distribution of survivorship care plans, particularly follow-up instructions, as a method to increase BCS and CCS among cancer survivors.

Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Kramer J, Siegel RL (2022) Cancer treatment and survivorship statistics, 2022, CA. Cancer J Clin 72:409–436. https://doi.org/10.3322/caac.21731CrossRef

de Gonzalez AB, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, Stovall M, Ron E (2011) The proportion of second cancers attributable to radiotherapy treatment in adults: a prospective cohort study in the US SEER cancer registries. Lancet Oncol 12:353–360. https://doi.org/10.1016/S1470-2045(11)70061-4CrossRefPubMedCentral

Matesich SMA, Shapiro CL (2003) Second cancers after breast cancer treatment. Semin Oncol 30:740–748. https://doi.org/10.1053/j.seminoncol.2003.08.022CrossRefPubMed

Donin N, Filson C, Drakaki A, Tan H-J, Castillo A, Kwan L, Litwin M, Chamie K (2016) Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer 122:3075–3086. https://doi.org/10.1002/cncr.30164

Bellizzi KM, Rowland JH, Jeffery DD, McNeel T (2005) Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol Off J Am Soc Clin Oncol 23:8884–8893. https://doi.org/10.1200/JCO.2005.02.2343CrossRef

McBean AM, Yu X, Virnig BA (2009) Screening mammography rate and predictors following treatment for colorectal cancer. J Cancer Surviv 3:12–20. https://doi.org/10.1007/s11764-009-0080-7CrossRefPubMed

Wilkins KL, Woodgate RL (2008) Preventing second cancers in cancer survivors. Oncol Nurs Forum 35:E12-22. https://doi.org/10.1188/08.ONF.E12-E22CrossRefPubMed

Earle CC, Neville BA (2004) Under use of necessary care among cancer survivors. Cancer 101:1712–1719. https://doi.org/10.1002/cncr.20560CrossRefPubMed

Uhlig A, Mei J, Baik I, Meyer C, Uhlig J (2018) Screening utilization among cancer survivors: a meta-analysis. J Public Health 40:129–137. https://doi.org/10.1093/pubmed/fdx030CrossRef

10.

Corkum M, Hayden JA, Kephart G, Urquhart R, Schlievert C, Porter G (2013) Screening for new primary cancers in cancer survivors compared to non-cancer controls: a systematic review and meta-analysis. J Cancer Surviv Res Pract 7:455–463. https://doi.org/10.1007/s11764-013-0278-6CrossRef

11.

Clarke TC, Soler-Vila H, Fleming LE, Christ SL, Lee DJ, Arheart KL (2012) Trends in adherence to recommended cancer screening: the US population and working cancer survivors. Front Oncol 2:190. https://doi.org/10.3389/fonc.2012.00190CrossRefPubMedPubMedCentral

12.

MacDonald M, Mirza A-S, Mhaskar R, Ewing A, Chen L, Robinson K, Lu Y, Ayoubi N, Gonzalez E, Guerra L, Roetzheim R, Woodard L, Pabbathi S (2022) Preventative cancer screening rates among uninsured patients in free clinics: a retrospective cohort study of cancer survivors and non-cancer survivors. Cancer Control J Moffitt Cancer Cent 29:10732748211072984. https://doi.org/10.1177/10732748211072983CrossRef

13.

Tsai M-H, Bevel MS, Andrzejak SE (2023) Racial/ethnic disparity in the relationship of mental and physical health with colorectal cancer screening utilization among breast and prostate cancer survivors. JCO Oncol Pract 19:e714–e724. https://doi.org/10.1200/OP.22.00718CrossRefPubMed

14.

McCabe MS, Bhatia S, Oeffinger KC, Reaman GH, Tyne C, Wollins DS, Hudson MM (2013) American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol Off J Am Soc Clin Oncol 31:631–640. https://doi.org/10.1200/JCO.2012.46.6854CrossRef

15.

Definition of survivorship care plan - NCI Dictionary of Cancer Terms - NCI (2011) https://www.cancer.gov/publications/dictionaries/cancer-terms/def/survivorship-care-plan. Accessed 19 Jan 2024

16.

Hill RE, Wakefield CE, Cohn RJ, Fardell JE, Brierley M-EE, Kothe E, Jacobsen PB, Hetherington K, Mercieca-Bebber R (2020) Survivorship care plans in cancer: a meta-analysis and systematic review of care plan outcomes. Oncologist 25:e351–e372. https://doi.org/10.1634/theoncologist.2019-0184CrossRefPubMed

17.

LaGrandeur W, Armin J, Howe CL, Ali-Akbarian L (2018) Survivorship care plan outcomes for primary care physicians, cancer survivors, and systems: a scoping review. J Cancer Surviv 12:334–347. https://doi.org/10.1007/s11764-017-0673-5CrossRefPubMed

18.

Shay LA, Schmidt S, Dioun SI, Grimes A, Embry L (2019) Receipt of a survivorship care plan and self-reported health behaviors among cancer survivors. J Cancer Surviv 13:180–186. https://doi.org/10.1007/s11764-019-00740-6CrossRefPubMedPubMedCentral

19.

Tsai M-H, Bevel MS, Andrzejak SE, Moore JX (2024) Receipt of follow-up care plans on colorectal cancer screening among breast, prostate, and lung cancer survivors. J Cancer Surviv Res Pract 18:781–790. https://doi.org/10.1007/s11764-022-01309-6CrossRef

20.

Chrischilles EA, McDowell BD, Rubenstein L, Charlton M, Pendergast J, Juarez GY, Arora NK (2015) Survivorship care planning and its influence on long-term patient-reported outcomes among colorectal and lung cancer survivors: The CanCORS disease-free survivor follow-up study. J Cancer Surviv Res Pract 9:269–278. https://doi.org/10.1007/s11764-014-0406-yCrossRef

21.

CDC - BRFSS (2023) https://www.cdc.gov/brfss/index.html. Accessed 8 Nov 2023

22.

Mayo M, Potugari B, Bzeih R, Scheidel C, Carrera C, Shellenberger RA (2021) Cancer screening during the COVID-19 pandemic: a systematic review and meta-analysis. Mayo Clin Proc Innov Qual Outcomes 5:1109–1117. https://doi.org/10.1016/j.mayocpiqo.2021.10.003CrossRefPubMedPubMedCentral

23.

US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Tseng C-W, Wong JB (2018) Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 320:674–686. https://doi.org/10.1001/jama.2018.10897

24.

Siu AL (2016) U.S. Preventive Services Task Force, Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 164:279–296. https://doi.org/10.7326/M15-2886

25.

U.S. Preventive Services Task Force (2009) Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 151:716–726. https://doi.org/10.7326/0003-4819-151-10-200911170-00008

26.

Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih Y-CT, Walter LC, Kim JJ, Andrews KS, DeSantis CE, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC, Smith RA (2020) Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin 70:321–346. https://doi.org/10.3322/caac.21628

27.

Perkins RB, Guido RL, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M, Feldman S (2021) Summary of current guidelines for cervical cancer screening and management of abnormal test results: 2016–2020. J Womens Health 2002(30):5–13. https://doi.org/10.1089/jwh.2020.8918CrossRef

28.

Mango V, Bryce Y, Morris EA, Gianotti E, Pinker K (2018) Commentary ACOG Practice Bulletin July 2017: breast cancer risk assessment and screening in average-risk women. Br J Radiol 91:20170907. https://doi.org/10.1259/bjr.20170907CrossRefPubMedPubMedCentral

29.

Tirona MT (2013) Breast cancer screening update. Am Fam Phys 87:274–278

30.

Centers for Disease Control and Prevention (CDC) (2018) Behavioral risk factor surveillance system survey questionnaire. Department of Health and Human Services, Centers for Disease Control and Prevention. Atlanta, Georgia: U.S. https://www.cdc.gov/brfss/questionnaires/

31.

van Jaarsveld CHM, Miles A, Edwards R, Wardle J (2006) Marriage and cancer prevention: does marital status and inviting both spouses together influence colorectal cancer screening participation? J Med Screen 13:172–176. https://doi.org/10.1177/096914130601300403CrossRefPubMed

32.

Benavidez GA (2021) Disparities in Meeting USPSTF breast, cervical, and colorectal cancer screening guidelines among women in the United States. Prev Chronic Dis 18. https://doi.org/10.5888/pcd18.200315

33.

Kressin NR, Manze M, Russell SL, Katz RV, Claudio C, Green BL, Wang MQ (2010) Self-reported willingness to have cancer screening and the effects of sociodemographic factors. J Natl Med Assoc 102:219. https://doi.org/10.1016/s0027-9684(15)30528-9CrossRefPubMed

34.

Maruthur NM, Bolen S, Gudzune K, Brancati FL, Clark JM (2012) Body mass index and colon cancer screening: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 21: 737–746. https://doi.org/10.1158/1055-9965.EPI-11-0826

35.

Centers for Disease Control and Prevention (CDC) (2019) BRFSS Complex Sampling Weights and Preparing 2018 BRFSS Module Data for Analysis. https://www.cdc.gov/brfss/annual_data/2018/pdf/Complex-Smple-Weights-Prep-Module-Data-Analysis-2018-508.pdf

36.

National Cancer Institute, Cancer Trends Progress Report (n.d.) https://progressreport.cancer.gov/detection/breast_cancer. Accessed 20 Oct 2024

37.

Tseng OL, Spinelli JJ, Dawes M, McBride ML (2017) Cervical cancer screening for survivors diagnosed with cancer before age 25. J Cancer Surviv 11:410–419. https://doi.org/10.1007/s11764-017-0598-zCrossRefPubMed

38.

Timsina LR, Zarzaur B, Haggstrom DA, Jenkins PC, Lustberg M, Obeng-Gyasi S (2021) Dissemination of cancer survivorship care plans: who is being left out? Support Care Cancer Off J Multinatl Assoc Support Care Cancer 29:4295–4302. https://doi.org/10.1007/s00520-020-05915-x

39.

Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC (2009) Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol Off J Am Soc Clin Oncol 27:2489–2495. https://doi.org/10.1200/JCO.2008.20.3232CrossRef

40.

Risendal BC, Sedjo RL, Giuliano AR, Vadaparampil S, Jacobsen PB, Kilbourn K, Barón A, Byers T (2016) Surveillance and beliefs about follow-up care among long-term breast cancer survivors: a comparison of primary care and oncology providers. J Cancer Surviv Res Pract 10:96–102. https://doi.org/10.1007/s11764-015-0454-yCrossRef

41.

Kenzik KM (2019) Health care use during cancer survivorship: review of 5 years of evidence. Cancer 125:673–680. https://doi.org/10.1002/cncr.31852CrossRefPubMed

42.

Snyder CF, Frick KD, Herbert RJ, Blackford AL, Neville BA, Lemke KW, Carducci MA, Wolff AC, Earle CC (2015) Comorbid condition care quality in cancer survivors: role of primary care and specialty providers and care coordination. J Cancer Surviv Res Pract 9:641–649. https://doi.org/10.1007/s11764-015-0440-4CrossRef

43.

Hollowell K, Olmsted CL, Richardson AS, Pittman HK, Bellin L, Tafra L, Verbanac KM (2010) American Society of Clinical Oncology-recommended surveillance and physician specialty among long-term breast cancer survivors. Cancer 116:2090–2098. https://doi.org/10.1002/cncr.25038CrossRefPubMed

44.

O’Connor JM, Sedghi T, Dhodapkar M, Kane MJ, Gross CP (2018) Factors associated with cancer disparities among low-, medium-, and high-income US counties. JAMA Netw Open 1:e183146. https://doi.org/10.1001/jamanetworkopen.2018.3146CrossRefPubMedPubMedCentral

45.

Abdelsattar ZM, Hendren S, Wong SL (2017) The impact of health insurance on cancer care in disadvantaged communities. Cancer 123:1219–1227. https://doi.org/10.1002/cncr.30431CrossRefPubMed

46.

Moss JL, Pinto CN, Srinivasan S, Cronin KA, Croyle RT (2020) Persistent poverty and cancer mortality rates: An analysis of county-level poverty designations. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 29:1949–1954. https://doi.org/10.1158/1055-9965.EPI-20-0007

47.

Halpern MT, McCabe MS, Burg MA (2016) The cancer survivorship journey: models of care, disparities, barriers, and future directions. Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet 35:231–239. https://doi.org/10.1200/EDBK_156039

48.

Birken SA, Raskin S, Zhang Y, Lane G, Zizzi A, Pratt-Chapman M (2019) Survivorship care plan implementation in US cancer programs: a national survey of cancer care providers. J Cancer Educ Off J Am Assoc Cancer Educ 34:614–622. https://doi.org/10.1007/s13187-018-1374-0

49.

Nelson HD, Cantor A, Wagner J, Jungbauer R, Fu R, Kondo K, Stillman L, Quiñones A (2020) Effectiveness of patient navigation to increase cancer screening in populations adversely affected by health disparities: a meta-analysis. J Gen Intern Med 35:3026–3035. https://doi.org/10.1007/s11606-020-06020-9CrossRefPubMedPubMedCentral

Title: Survivorship care plans and adherence to breast and cervical cancer screening guidelines among cancer survivors in a national sample
Authors: Marco Santos-Teles
Ganesh Modugu
Isabel C. Silva
Elisa V. Bandera
Mridula George
Bo Qin
Jonathan Smith
Ruth Stephenson
Malcolm D. Mattes
Mariam F. Eskander
Publication date: 01-12-2024
Publisher: Springer Berlin Heidelberg
Keywords: Cervical Cancer
Cervical Cancer
Breast Cancer
Breast Cancer
Published in: Supportive Care in Cancer / Issue 12/2024
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-024-08986-2

Topical use of chicory root extract gel on the incidence and severity of radiodermatitis in breast cancer patients: a randomized controled trial

Breast Cancer
Research

Exercising and immuno-oncology treatment (ExIO): a prospective pilot study for patients with solid tumors

Checkpoint Inhibitors
Research

Perceptions, facilitators, and barriers of participation for a behavioral weight loss group-based telehealth program for breast cancer survivors: a qualitative study

Open Access
Breast Cancer
Research

Letter to the editor to “Outcomes of parenteral nutrition in patients with advanced cancer and malignant bowel obstruction”

Nutrition
Correspondence

Incidence and impact of food aversions among patients with cancer receiving outpatient chemotherapy: a one-year prospective survey

Open Access
Cytostatic Therapy
Research

Identifying unmet needs in cancer survivorship by linking patient-reported outcome measures to the International Classification of Functioning, Disability and Health

Open Access
Premature Rupture of Membranes
Review

ASH 2024 Annual Meeting Coverage

inMIND supports tafasitamab addition in follicular lymphoma

12-12-2024
Lymphoma
News

Combining tafasitamab with lenalidomide and rituximab significantly improves progression-free survival for patients with relapsed or refractory follicular lymphoma.

Featuring the official presentation video

12-12-2024
Mantle Cell Lymphoma
News

Add-on blinatumomab improves DFS in children with ALL

Promising response to loncastuximab tesirine in lymphoma

12-12-2024
Lymphoma
News

» View more highlights on the ASH 2024 hub page

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Targeted Therapy
On-demand webinar

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Keynote series | Spotlight on menopause

Springer Medicine

Survivorship care plans and adherence to breast and cervical cancer screening guidelines among cancer survivors in a national sample

Abstract

Purpose

Methods

Results

Conclusions

Other articles of this Issue 12/2024

Topical use of chicory root extract gel on the incidence and severity of radiodermatitis in breast cancer patients: a randomized controled trial

Exercising and immuno-oncology treatment (ExIO): a prospective pilot study for patients with solid tumors

Perceptions, facilitators, and barriers of participation for a behavioral weight loss group-based telehealth program for breast cancer survivors: a qualitative study

Letter to the editor to “Outcomes of parenteral nutrition in patients with advanced cancer and malignant bowel obstruction”

Incidence and impact of food aversions among patients with cancer receiving outpatient chemotherapy: a one-year prospective survey

Identifying unmet needs in cancer survivorship by linking patient-reported outcome measures to the International Classification of Functioning, Disability and Health

ASH 2024 Annual Meeting Coverage

inMIND supports tafasitamab addition in follicular lymphoma

Transplantation can be omitted for certain MCL patients

Add-on blinatumomab improves DFS in children with ALL

Promising response to loncastuximab tesirine in lymphoma

» View more highlights on the ASH 2024 hub page

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Keynote series | Spotlight on menopause

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

ASH 2024 Annual Meeting Coverage